G. Clare Kahn

G. Clare Kahn

DirectoratStoke Therapeutics· In the 2025 proxy

G. Clare Kahn sits on 1 public board.

Experience

  1. Stoke TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role +133%
  2. Solid Biosciences Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?